Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lora DiCarlo was a prominent femtech company that specialized in the development of biomimetic robotic sexual wellness devices. Founded in 2017, the company gained international recognition for its flagship product, Osé, which utilized micro-robotics to simulate human touch. The firm was at the center of a major industry controversy when its CES Innovation Award was revoked due to "obscenity" policies, leading to a successful campaign for policy changes at the Consumer Technology Association. Despite raising significant venture capital and expanding its product line to include various robotic massagers, the company reportedly ceased operations in early 2023. Its technology was developed in collaboration with the Oregon State University College of Engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lora DiCarlo.